Cet article est réservé aux membres

Déjà membre ?

Log In

Not a member ?

Free registration
Evotec, X-Chem to Collaborate on Early-Stage Drug Discovery MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday MT
Evotec Chief Business Officer Matthias Evers Steps Down MT
Evotec Q2 Loss Widens, Revenue Rises MT
Sector Update: Health Care Stocks Edge Higher Premarket Tuesday MT
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Investors Focus on Inflation Data Releases MT
Evotec Reports Progress in Partnership With Bristol-Myers Squibb MT
Evotec Receives $25 Million Under Neuroscience Partnership With Bristol-Myers Squibb MT
Morgan Stanley Downgrades Evotec to Equalweight From Overweight, Cuts Price Target to $6 From $15 MT
Morgan Stanley Downgrades Evotec SE to Equalweight From Overweight, Adjusts Price Target to $6 From $15 MT
Sector Update: Health Care Stocks Steady Premarket Wednesday MT
Evotec, Pfizer Enter Research Collaboration on Metabolic, Infectious Diseases MT
Evotec's Biologics Segment Expands Sandoz Partnership MT
Sector Update: Health Care Stocks Advance Pre-Bell Tuesday MT
Evotec Subsidiary Gets Multi-Year US Defense Department Contract for Up to $39 Million MT
Evotec Gets $20 Million Milestone Payment in Neurodegenerative Disease Collaboration With Bristol Myers Squibb MT
Evotec Partners With French Institutions, Company to Research Obesity MT
Evotec Extends Drug Discovery Collaboration With CHDI Foundation for Huntington's Disease MT
Evotec Shares Rise Following Gene Therapy Exit, Q1 Results MT
Evotec Q1 Net Loss Widens as Revenue Falls MT
Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment MT
Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies MT
H.C. Wainwright Adjusts Price Target on Evotec to $11 From $14, Keeps Buy Rating MT
Top Midday Decliners MT
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday MT
Chart Eaton Vance Ohio Municipal Income Trust
More charts
Logo Eaton Vance Ohio Municipal Income Trust
Eaton Vance Ohio Municipal Income Trust (the Trust) is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income exempt from regular federal income tax and taxes in its specified state. The Trust invests in debt securities issued by Ohio municipalities. The Trust has investments in various sectors, including education, electric utilities, escrowed/prerefunded, general obligations, hospital, housing, industrial development revenue, senior living/life care, transportation, and water and sewer. The Trust may invest in residual interest bonds, also referred to as inverse floating rate securities, whereby the Trust may sell a variable or fixed rate bond for cash to a Special-Purpose Vehicle (the SPV), while at the same time, buying a residual interest in the assets and cash flows of the SPV. The Trust's investment advisor is Eaton Vance Management.
Employees
0
More about the company
  1. Stock Market
  2. Equities
  3. EVO Stock
  4. News Eaton Vance Ohio Municipal Income Trust
  5. Evotec Receives $25 Million Under Neuroscience Partnership With Bristol-Myers Squibb
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW